Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sigal Elliot
Relationship:   Director
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   148,221    

Indirect Shares

   78,638      
Direct Value   $5,965,895    

Indirect Value

   $5,479,085      
Total Shares   226,859      
Total Value   $11,444,981      


Bristol-Myers Squibb Co $5,965,895 Bristol-Myers Squibb Co $5,965,895
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY EVP, CSO & President R... 2013-06-03 148,221 2013-06-03 47,079    Premium*  
            Mead Johnson Nutrition Co MJN Director 2017-06-15 0 2017-06-15 0    Premium*  
            Spark Therapeutics, Inc. ONCE Director 2019-12-17 0 2015-02-04 31,559    Premium*  
* Premium Members only  

Records found :    133         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-06 4 D $32.33 $1,286,217 D/D (39,784) 298,840 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-09-05 4 D $0.00 $0 D/D (250,788) 298,840 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-11-27 4 GA $0.00 $0 I/I 200,630 100,315 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-11-27 4 GD $0.00 $0 I/I 200,630 50,158 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-12-11 4 S $33.00 $5,189,481 I/I (157,257) 37,412 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-02-08 4 OE $17.51 $5,536,826 D/D 266,082 314,134 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-02-08 4 S $36.79 $8,266,897 D/D (224,705) 89,429 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-03 4 D $37.15 $893,123 D/D (24,041) 111,753 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-03 4 OE $0.00 $0 D/D 46,365 135,794 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-04 4 OE $0.00 $0 D/D 7,453 119,206 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-04 4 D $36.94 $142,773 D/D (3,865) 115,341 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-07 4 D $37.53 $2,816,214 D/D (75,039) 185,021 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-07 4 A $0.00 $0 D/D 12,329 260,060 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-07 4 OE $0.00 $0 D/D 132,390 247,731 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-29 4 S $39.90 $4,188,026 D/D (104,918) 153,493 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-29 4 OE $22.73 $1,763,821 D/D 73,390 258,411 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-29 4 S $39.97 $1,829,947 I/I (45,783) 9,550 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-30 4 S $39.65 $91,076 I/I (2,297) 9,091 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-30 4 S $39.61 $14,004,254 D/D (353,509) 105,889 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-30 4 OE $24.74 $7,641,575 D/D 305,905 459,398 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-05-30 4 OE $24.74 $4,495,081 D/D 170,625 276,514 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-05-30 4 S $47.23 $6,778,497 D/D (143,521) 132,993 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-06-03 4 S $48.18 $4,030,112 D/D (83,647) 148,221 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-06-03 4 OE $27.01 $2,670,614 D/D 98,875 231,868 0 -
MJN Mead Johnson Nutrition Co Director   –       •      –    2009-03-10 3 IO $0.00 $0 D/D 0 5,000 -
  133  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us